Recent advancements in stroke research have focused on understanding and managing acute ischemic stroke through reperfusion therapies aimed at restoring blood flow to the brain quickly.
Many stroke survivors still face significant functional impairments post-treatment, prompting researchers to explore brain recovery and regeneration beyond the acute phase of care.
Stroke disrupts the neurovascular unit (NVU), leading to compromised blood-brain barrier integrity, glial activation, neuronal injury, and chronic inflammation, hindering natural recovery processes.
Reprogramming the brain post-stroke involves shifts in gene expression patterns towards regeneration, cellular plasticity within the NVU, and neural circuit reorganization to restore functionality.
Understanding gene expression dynamics post-stroke can unveil pathways regulating inflammation, angiogenesis, and synaptic remodeling, offering targets for therapeutic interventions.
Endogenous cellular transdifferentiation within the NVU shows promise for brain repair by stimulating native cells to change identity, potentially revolutionizing regenerative medicine.
Remodeling neural networks post-stroke, involving brain plasticity and network reorganization, is crucial for restoring motor skills, speech, and cognitive functions, often recruiting alternate brain regions for compensation.
An integrated approach to stroke recovery combines genetic and cellular therapies with social rehabilitative strategies to optimize outcomes, recognizing the importance of timing in therapeutic efficacy.
Challenges in stroke recovery include the complexity of NVU interactions, stroke phenotypic diversity, and the need for precise immune modulation without exacerbating damage, requiring advanced computational and personalized medicine strategies.
Advancements in single-cell sequencing, spatial transcriptomics, and AI-powered analyses offer unprecedented insights into stroke-induced changes, paving the way for tailored gene- and cell-based treatments for personalized stroke therapy.
Efforts to translate laboratory findings to clinical practice necessitate interdisciplinary collaboration, the establishment of comprehensive stroke recovery centers, and regulatory adaptations to accommodate combined therapies modulating genes, cells, and networks in stroke treatment.